Studiu de caz

Specialist PV support transforms safety for orphan medicinal products

Explore the case study to learn how Cencora supported a UK company developing two orphan-designated, centrally authorized drugs after challenges with a prior provider. 

Key highlights

Following a successful safety database migration, Cencora delivered an integrated, single-provider pharmacovigilance model across the EU, UK, and Switzerland, including QPPV coverage, local PV set-up, PSMF and EudraVigilance maintenance, case management, and clinical trial safety oversight. The outcome was improved compliance, streamlined operations, and strengthened audit readiness.

Download to learn more

Pardot Form

Suntem aici pentru a vă ajuta

Luați legătura cu echipa noastră astăzi pentru a afla mai multe despre modul în care Cencora contribuie la modelarea viitorului serviciilor medicale.

Resurse conexe

Studiu de caz

Boosting quality and reducing complexity with a single-provider PV solution
Mai multe detalii

Studiu de caz

Streamlining European expansion with integrated PV, regulatory, and commercial expertise
Mai multe detalii

Articol

Adoptarea unei abordări strategice de gestionare a activităților fotovoltaice pentru portofoliul matur
Mai multe detalii